Toggle navigation
Home
Search
Services
Blog
Contact
About
DNA Repair and Cisplatin Resistance in Ovarian Cancer
Johnson, Steven W.
Fox Chase Cancer Center, Philadelphia, PA, United States
Search 141 grants from Steven Johnson
Search grants from Fox Chase Cancer Center
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The Dog Aging Project: Genetic and Environmental Determinants of Healthy Aging in Companion Dogs Competitive Revision
Physical Activity and Pelvic Floor Disorders
Reovirus Sigma 3 - Structural and Regulatory Functions
NIH Intramural Nrsa Institutional Training Program
Pharmacology Studies with Diazohydoxide
Recently added grants:
Lipoprotein and HDL Function Core
Lipid Peroxidation Analytical Core
Non-Coding RNA Analytical Core
Dicarbonyl Scavengers to Improve HDL Function and Reduce Atherosclerosis in FH
Modified Intestinal apoAI-particles and Lymphatics Accelerate CKD-driven CVD
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32CA009301-01
Application #
3034759
Study Section
Physiological Sciences Study Section (PSF)
Project Start
1992-08-10
Project End
Budget Start
1992-03-02
Budget End
1993-03-01
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Institution
Name
Fox Chase Cancer Center
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Related projects
NIH 1993
F32 CA
DNA Repair and Cisplatin Resistance in Ovarian Cancer
Johnson, Steven W. / Fox Chase Cancer Center
NIH 1992
F32 CA
DNA Repair and Cisplatin Resistance in Ovarian Cancer
Johnson, Steven W. / Fox Chase Cancer Center
Publications
Johnson, S W; Swiggard, P A; Handel, L M et al.
(1994)
Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cells.
Cancer Res 54:5911-6
Comments
Be the first to comment on Steven Johnson's grant